Rwanda vaccinates 10% of population, reaches first global target

Kigali, 20 September 2021 – Rwanda has fully vaccinated 10% of its population against COVID-19, reaching the September global target by the World Health Organization (WHO) aimed at widening vaccination and helping to turn the tide against the pandemic. 

“I am delighted at this significant achievement,” said Dr Salla Ndoungou Ba, WHO Representative ad interim in Rwanda. “Rwanda has been a model of good practice in the region since the beginning of its vaccination programme in March. I congratulate the Government of Rwanda and its partners for their sustained effort to protect the people of Rwanda against COVID-19.”

In May 2021, WHO Director-General, Dr Tedros Adhanom Ghebreyesus, set the global target of 10% of the populations of all countries to be inoculated by the end of September; 40% by the end of December; and 70% by mid-2022. 

The global targets have been set to reach critical milestones in countries’ COVID-19 vaccine responses. 10% of the population inoculated should offer protection to the most vulnerable; 40% should keep priority populations such as health care workers, older people, and people with comorbidities safe, and 70% will reopen societies and economies. 

Almost 90% of high-income countries have now reached the 10% target, and more than 70% have reached the 40% target. Only 14 countries in the African continent achieved the first target and three countries have achieved 40% target.  

Rwanda has so far received around 3.4 million doses of COVID-19 vaccines – 1.1 million of these from The COVAX Facility, 108 000 from the Africa Centres for Disease Control’s Africa Vaccine Acquisition Trust; and 2.1 million from bilateral agreements. Of these, it has administered 3.3 million doses and fully vaccinated 10% of its 13 million people. 

Building on the success of Rwanda’s routine immunization system, COVID-19 vaccination has been rolled out smoothly with minimal hesitancy. The country is committed to reach as many people as possible in each targeted group and to make this happen, vaccine distribution has been facilitated by air, road and water, allowing a simultaneous vaccination roll-out country wide. 

To address the shortage in vaccine supply which slowed down the vaccination pace from April to June, the Government of Rwanda engaged with vaccine manufacturers to access more vaccine doses through bilateral agreements while continuing its engagement with COVAX Facility. The strong leadership and good governance observed in Rwanda has been the foundation and driving force behind innovations and successes.  

The supply shortages in Africa from April to July caused uncertainty and insecurity among countries in Africa, ultimately impacting on their vaccine uptake. Coupled with operational bottlenecks and some measure of vaccine hesitancy, only 54 million people in Africa, or 4% of the population, have been fully vaccinated against COVID-19. 

Despite challenges, many countries adopted innovative and flexible vaccine delivery strategies in a bid to get as many jabs into arms as possible. 

WHO is supporting the Government of Rwanda to reach the country’s target to vaccinate 60% of Rwandans by 2022.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
4 Benefits of Morning Running for Health thumbnail

4 Benefits of Morning Running for Health

JOGGING memang memliki banyak manfaat bagi kesehatan. Selain untuk menjaga imunitas, jogging juga bisa membakal kalori sehingga menjaga berat badan Anda tetap stabil. Apalagi, lari adalah salah satu olahraga yang dan tidak membutuhkan banyak biaya. Jogging sebenarnya bisa dilakukan kapan saja, namun banyak orang memilih untuk jogging di pagi hari. Tujuan utama jogging adalah untuk…
Read More
DIE NEUSTEN ENTWICKLUNGEN -Update Corona: 40 Prozent der Infizierten leiden an Long Covid, aber auch Nicht-Infizierte klagen über Symptome thumbnail

DIE NEUSTEN ENTWICKLUNGEN -Update Corona: 40 Prozent der Infizierten leiden an Long Covid, aber auch Nicht-Infizierte klagen über Symptome

Die neusten Entwicklungen 40 Prozent der Infizierten leiden an Long Covid, aber auch Nicht-Infizierte klagen über Symptome. Ein amerikanischer Forscher sieht «starke Evidenz, dass ein Markt in Wuhan Ausgangsort der Corona-Pandemie war». Auch Geimpfte können bei einer Corona-Infektion ansteckend sein. Diese und weitere Forschungsergebnisse zu Sars-CoV-2 und Covid-19. llustration: Christian KleebIm Frühjahr 2020 wussten wir…
Read More
Growing Controversy Over 'Skinny' Labeling for Generic Drugs thumbnail

Growing Controversy Over ‘Skinny’ Labeling for Generic Drugs

The vast majority of patients who initiated imatinib therapy for gastrointestinal stromal tumors (GISTs) received a generic drug that did not have FDA approval for that indication, a large retrospective review showed. Almost half of the 2,000 patients in the review of imatinib initiators had chronic myeloid leukemia (CML), while about a third had GIST.…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?